ENSACOVE

ensartinib · Xcovery Holdings, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ENSACOVE, covering 2024-12-18 to 2026-02-26. Get the full timeline:

Most recent: FDA Approved: ENSACOVE — Supplemental Application (Xcovery Holdings, Inc.)